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Abstract 
Objective: To explore the frequency, and types of congenital heart defects (CHD) and Thyroid disorders in 
children with Down syndrome (DS) in the children's hospital and the institute of child health (CHICH) Multan. 
Study design: Descriptive cross-sectional. 
Setting: Outpatient department (OPD) of CHICH Multan. 
Material and Methods: A total of 158 Down Syndrome (DS) patients of 0 to 15 years of age, of both genders, were 
included in this study from October 2019 to October 2020. DS was diagnosed by specific clinical features and 
karyotyping. Age, sex, and mother’s age were noted. Blood samples of all the patients were sent for karyotyping 
and serum T4 and thyroid stimulation hormone (TSH). For patients more than 36 months, blood samples were 
also sent for antithyroglobulin and antithyroid peroxidase antibodies. Echocardiography of all the patients was 
done. Data was collected and analyzed by using SPSS version 16.0.  
Results: Out of 158 DS children 81 (51.5%) presented below 6 months of age, with a male to female ratio of 1:1.4. 
79 (50%) mothers were between 20 to 40 years of age. Karyotyping revealed non-disjunction in 97% of cases. 
Cardiac abnormalities were found in 48% of DS children. The most common Type was VSD (10.9%), Thyroid 
abnormalities were detected in 24% of DS patients and subclinical hypothyroidism (13.9%) was most common. 
Conclusion: CHD and thyroid disorders must be ruled out in all DS patients, to start early management.  
Keywords: Down syndrome, congenital heart disease, hypothyroidism. 
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Introduction 
 
DS is the most common chromosomal abnormality in 
humans with a prevalence of 1 in 700-1500 live births.1 
The basic mechanism of this syndrome is trisomy of 
chromosome 21 in all or some of the body cells.2 Non-
disjunction is responsible for 95% of cases, while 
translocation or mosaicism for the rest of the cases.3-5 
DS is the most common genetic cause of intellectual 
disability worldwide and other health issues like 
congenital heart defects (CHD), thyroid dysfunctions, 
hematopoietic disorders, early-onset Alzheimer 
disease, gastrointestinal disorders, neuromuscular 
weakness, hearing and visual problems, typical facial 
and physical features, and a high frequency of other 
medical conditions.6-9 
Thyroid dysfunction is the commonest among the 
endocrine abnormalities, found in 4-8% of children 
with Down syndrome.3 In DS patients, the spectrum of 
thyroid dysfunction includes overt, subclinical, or 
acquired hypothyroidism, as well as 
hyperthyroidism.10 The prevalence of thyroid 
disorders is higher than the general population in DS 
patients. These patients most commonly suffered from 
subclinical and congenital hypothyroidism (CH).1,11-15 
Nermine H. Amr. reported prevalence of subclinical 
and congenital hypothyroidism as 7-40 and 28-35 
times higher than the general population respectively.3 
Hyperthyroidism is mainly due to graves’ disease in 
DS patients.16 
CH is also the preventable cause of mental retardation 
and increases the risk of other disorders like congenital 
heart and gastrointestinal as compared to DS without 
CH17, so early diagnoses and management of CH in DS 
patient can reduce the morbidity.  
Another health issue in DS is CHD, which is also the 
main cause of morbidity and mortality in DS especially 
within the first two years of life.18 In DS children, 
variation in the prevalence of CHD, frequency, and 
associations of its different types have been observed 
not only from country to country but also among 
different areas of the same country. It may be due to 
different inclusion criteria about the size and age of 
the study population. 
A study from Egypt reported 36.9% a Prevalence of 
CHD in DS.19 However, In Pakistan prevalence is 
reported at 41.8%.20 Regarding frequency and 
association of CHD, Sanaa Benhaourech described 
atrioventricular septal defect (AVSD) (42.2%) as the 
most common CHD, followed by ventricular septal 
defect VSD (31.3%).21  
This study aimed to determine the frequency and 
types of CHD and thyroid dysfunction among DS 
children in south Punjab and to compare our data with 
other studies.  
 
Materials and Methods 
 
This descriptive cross-sectional study was conducted 
in the Out-patient Department (OPD) of the CH & ICH 
Multan. A total of 158 DS patients of 0 to 15 years of 
age, of both genders, were recruited from 
developmental pediatrics, pediatric cardiology, and 
endocrinology OPD from October 2019 to October 
2020. 
After taking written consent from parents or 
guardians, detailed history was taken from 
parents/guardians and patients. The age, sex, and age 
of the mother were noted. DS was diagnosed by 
specific clinical features1 and karyotyping.1-22 Age was 
divided into 3 groups, 0-6 months, >6-36 months, and 
>36 months-15 years. For karyotyping, 3-5 cc venous 
blood was collected and sent to the laboratory. 
 For identifying thyroid disorders serum T4 and TSH 
levels of all patients were sent to hospital laboratory 
assessed by ACCESS-2 Immunodiagnostic system 
(BECKMAN COULTER) using Chemiluminescence 
technology. The blood sample of DS children in the 
age group between 36months to 15 years was also sent 
for Antithyroglobulin and antithyroid peroxidase 
antibodies. After the result, children were labelled as 
euthyroid if T4 and TSH were normal, overt 
hypothyroid if T4 was low and TSH high, subclinical 
hypothyroidism with normal T4 and high TSH. 
Autoimmune hypothyroidism was diagnosed with 
low T4, high TSH, and the presence of one or both 
Antithyroglobulin and antithyroid peroxidase 
antibodies. For detecting hyperthyroidism T4 was high 
with low or normal TSH.20,23 
All the DS children were sent to the pediatric 
cardiology department for echocardiography by a 
consultant cardiologist for the diagnosis of CHD and 
identifying its type. Wherever multiple cardiac lesions 
were found in the same patient, the leading lesion was 
taken as the main lesion. Patent foramen ovale, 
bicuspid aortic valve without significant aortic stenosis 
or regurgitation were considered as normal   
All the information was noted on predesigned 
Performa and the collected data was analyzed through 
SPSS version 16.0. Descriptive statistics were applied. 
The frequency and percentages of all the variables 
were calculated. The relationship of types of CHD and 
thyroid disorder with DS was assessed by using the 
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chi-square test. P-value was calculated, which is 
considered significant if ≤0.05. 
The study was approved by the institutional ethical 
committee. No conflict of interest was involved in this 
study. No financial support was provided by the 
institution or pharmaceutical company. Due 
autonomy, beneficence, confidentiality, and non-
maleficence were ensured to the patients. 
 
Results 
 
Out of 158 DS children most belonged to the age group 
0-6months with a male to female ratio of 1:1.4. Most 
mothers were between 20 to 40 years of age. 
Karyotyping revealed non-disjunction as a cause of 
trisomy in most of the children. Cardiac abnormalities 
were found in 48% of DS children and the most 
common defect was ventricular septal defect (VSD) 
with a p-value of <0.01. Thyroid abnormalities were 
detected in 24% of DS patients, subclinical 
hypothyroidism (p-value=<0.01) was most common. 
The basic characteristics of patients are shown in Table 
1. The frequency of congenital heart and thyroid 
disorders are described in Tables 2, and 3 respectively. 
 
Table 1: Basic Characteristics (N=158) 
Variables N % 
Age 
0-6 months 
>6-36 months 
>36months-15years 
 
81 
61 
16 
 
51.1 
38.6 
6.3 
Gender 
Male 
Female 
 
88 
70 
 
55.7 
44.3 
Age of mother 
<20 years 
>20-40 years 
>40 years 
 
50 
79 
29 
 
31.6 
50 
18.4 
Karyotyping 
Non-disjunction 
Translocation 
Mosaic 
 
153 
3 
2 
 
97 
1.8 
1.2 
 
Table 2: Different Types of Cardiac Lesions in 
Children with Down Syndrome (N=158) 
Findings n % 
     Normal Heart 82 52 
     Cardiac lesions 76 48 
Type of cardiac lesion 
     Ventricular septal defect 16 10.2 
     Complete atrioventricular septal 
defect 
15 9.5 
     Patent ductus arteriosus 14 8.9 
     Atrial septal defect 11 6.9 
     Tetralogy of Fallot 05 3.2 
     Severe pulmonary hypertension 04 2.6 
     Tricuspid Atresia 03 1.9 
     Univentricular heart 02 1.2 
     Pulmonary Atresia 01 0.6 
     Pulmonary Stenosis 01 0.6 
     Coarctation of aorta 01 0.6 
     Ebstein Anomaly 01 0.6 
 
Table 3: Different Types of Thyroid Disorders in 
Children with Down Syndrome (N=158) 
Type of Thyroid disorders n % 
Normal (euthyroid) 120 76 
        Thyroid disorders 38 24 
Hypothyroidism   
        Overt 7 4.4 
        Subclinical 22 13.9 
        Autoimmune 4 2.5 
Hyperthyroidism 5 3.2 
 
Discussion 
 
This study is conducted to know the frequency of 
CHD and thyroid disorders in DS children presenting 
to OPD. Most of the children were presented below 6 
months of life which is similar to some other studies 
conducted in children's hospitals Lahore20 and Brazil.24 
Chromosomal analysis is still a gold standard for the 
diagnosis of DS. Karyotyping revealed trisomy by 
non-disjunction as a most common finding in our 
study which is favored by the results of other studies 
of Pakistan20,25 and Egypt.26 Mostly the mothers of DS 
children belongs to 20-40 years of age, while Mia 
Sotonica et al describes the highest occurrence of DS 
with mothers from 30 to 39 years old with trisomy as a 
major type of down syndrome (86.6%).27 
In the present study frequency of CHD is 48%, which 
is almost similar to the prevalence found in Lahore 
(41.8%).20 Studies done in other countries like Egypt19, 
Nigeria28, Iran29, and Thailand30 also reported a high 
prevalence of CHD in DS i.e.36.9%, 79.7%, 74.1%, 
67.8% respectively. Regarding types of CHD we found 
mostly isolated lesions, VSD the most common i.e. 
10.2%, followed by AVSD 9.5%, PDA 8.9%, and ASD 
6.9%. Other less common CHD were severe 
pulmonary hypertension 2.6%, Tricuspid Atresia 1.9%, 
Univentricular heart 1.2%, Ebstein Anomaly 0.6%. 
Studies in Lahore20and Egypt also described the same 
results, in isolated cardiac lesions, the most common is 
216                                                                             Journal of Rawalpindi Medical College (JRMC); 2021; 25(2): 213-217  
VSD (41% & 14.7% respectively).19 While some other 
studies in Thailand30, Guatemala31, and Nigeria28, 
showed AVSD as the most common defect, (12.5%, 
11.6%, 39.2% respectively). We found PDA as 3rd most 
common defect while studies of Nigeria28 and USA32 
do not find any isolated PDA case. We have only one 
case of coarctation of the aorta but the study at 
Lahore20 does not find any case, while the Thai30 study 
has 2 cases. Pulmonary stenosis, Pulmonary atresia, 
pulmonary HTN, Ebstein anomaly, and univentricular 
heart are diagnosed in this study although in low 
proportions other studies do not describe these as an 
isolated lesion,31,28 in comparison local study only 
diagnose PS and pulmonary HTN in few cases.20 
Tetralogy of Fallot (3.2%), and TGA+ VSD +PS (1.2%) 
are multiple cardiac defects found in our study. 
Another national study found VSD+PDA, VSD+ASD, 
AVSD+PDA, VSD+bilateral superior vena cava, and 
VSD+double outlet right ventricle. While an 
international study found VSD+PDA and VSD+ASD 
as multiple cardiac lesions.19,20 
The present study detects thyroid disorders in 24% of 
DS children which is similar to other study20, while 
others conducted by lughatti in Italy, Ali et al in 
Kuwait, and Unachak in Thailand show a higher 
prevalence of this association33,34,35Hypothyroidism 
(overt) is mainly found in 4.4% of DS children which is 
consistent with other studies in Lahore, Thailand, and 
Nepal.20,35,36 Subclinical hypothyroidism is diagnosed 
in 13.9% of DS children which co-relate with other 
studies (prevalence ranging between 12.5-
32.5%).20,34,35,36,37,38,39 Subclinical hypothyroidism is 
asymptomatic, Diagnosis of all types of 
hypothyroidism in children with DS is important as it 
requires timely treatment in the form of thyroxin 
replacement therapy to prevent further intellectual 
deterioration. We have a very low frequency of 
autoimmune defect i.e. 2.5% which is favored by 
others too.20,39 
Hyperthyroidism was only detected in 3.2% of cases. 
Other studies also indicate that the prevalence of 
hyperthyroidism is less common as compared to 
hypothyroidism in DS patients.20,34,35,36,37,38,39 
 
Limitations 
  
It was a Single-center study without long-term follow-
up. We did not focus on the impact of thyroid 
dysfunction or cardiac lesions on the patients. A multi-
center study will long term follow up and the impact 
of co-morbidities on DS patients should be planned. 
 
Conclusion 
  
CHD and thyroid disorders are commonly present in 
DS children. The clinical manifestations of CHD like 
cyanosis, tachypnea, tachycardia, abnormal precordial 
impulse, or a murmur may not appear so early in DS 
children, similarly, hypothyroidism also remains 
asymptomatic in most patients. So diagnostic 
investigations like (X-ray chest, electrocardiography, 
and echocardiography, Thyroid profile) must be 
carried out on all DS patients to rule out cardiac and 
thyroid lesions and to start early management. Early 
detection and management of these defects can 
decrease mortality and morbidity and can improve the 
quality of life of these patients. 
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